MRI first, or straight to biopsy
Why the order matters, what the scan saves you from, and when a biopsy is genuinely the right call.
Written and reviewed by Mr Ashwin Sridhar, Consultant Urological Surgeon
- Of men avoid a biopsy altogether
- 25 to 30%
- A biopsy is always a planned separate step
- Never on day one
- The scale your scan is scored on
- 1 to 5
Why the order matters
Scanning before sampling changes how many men need a needle at all.
For decades, the standard way medicine investigated a raised PSA was to send a man straight for a biopsy, passing needles blindly through the back passage to sample random areas of the prostate. It was essentially like playing an uncomfortable game of pin the tail on the donkey. Because the needles were firing into the prostate under ultrasound control without aiming at anything in particular, without an image to guide them, they frequently missed small, aggressive tumours that sat just outside the sampling grid.
The international standard changed because landmark clinical research, specifically major trials like PROMIS and PRECISION led here in the UK, proved that performing an advanced multiparametric MRI before even considering a biopsy transforms outcomes for patients.
What the evidence showed was clear in two ways. First, a high-quality MRI allows a substantial proportion of men with a raised PSA to safely skip having an invasive biopsy altogether. If your scan comes back completely clear and your PSA density is low, we know with exceptional reliability that you do not harbour significant cancer.
Second, for the men whose scans do show an area of interest, the MRI acts like a high-definition GPS navigation system. Instead of firing random needles into normal tissue, we use the scan to perform a targeted biopsy, fusing the MRI images in theatre so we guide the needle directly into the exact suspicious lesion. This makes the check far more accurate. It improves our ability to find aggressive cancers early, when they are completely curable, while cutting down on the overdiagnosis of insignificant conditions that lead to unnecessary treatment.
What the scan saves you from
The greatest benefit of scanning first is often not what we find, but what you never have to go through.
In routine clinical practice, a high-quality multiparametric MRI combined with a low PSA density allows between twenty-five and thirty percent of men with an elevated PSA to walk away safely without needing a biopsy at all.
Avoiding an unnecessary biopsy spares a man from a genuinely uncomfortable and physically invasive procedure. Even with modern transperineal techniques, having biopsy needles passed into the prostate involves local or general anaesthetic, surgical theatre time, and days of bruised discomfort. In the days following, men frequently experience visible blood in their urine, bleeding from the back passage, and dark, rust-coloured blood in their semen that can persist for several weeks, which is often deeply unsettling.
Every prostate biopsy also carries real clinical risks: temporary urinary retention, where swelling around the prostate makes it difficult to pass water and requires a temporary catheter, and the risk of urinary infection or, rarely, severe sepsis needing emergency admission.
Just as important is the psychological toll of overdiagnosis. Blind or unnecessary biopsies frequently stumble across tiny, low-grade, indolent cellular changes, microscopic specks of low-risk tissue that would never have grown, spread or caused any harm during a man's natural lifespan. Once those cells are labelled with the word cancer on a pathology report, it triggers a profound emotional shock. Men suddenly find themselves carrying the anxiety of a cancer diagnosis, facing repeat hospital visits, continuous blood tests, and pressure to undergo treatment or surveillance they never truly needed.
By using the MRI as a frontline gatekeeper, we filter out that cascade of pain, infection risk and distress, so an invasive procedure is only ever recommended when there is a clear, targetable reason for it.
Who genuinely needs a scan, and who does not
Two short lists. If you recognise yourself in the first, a scan is worth having.
- A scan helps
- A repeat test confirms a raised PSA. The prostate feels uneven, firm or has a lump on examination, even with a low PSA. The PSA has climbed steadily across two or three checks. A father or brother diagnosed under 60, or a gene like BRCA2, with numbers on the higher side of normal.
- A scan does not
- Numbers and examination are both normal. Ordinary ageing symptoms, waking once or twice at night, with a completely normal PSA. A spike straight after an infection. Let the tissue heal and re-test.
The full version, including the harmless reasons a PSA can be raised, is on a raised PSA is not a diagnosis.
When a biopsy is the right call
If your scan does show something, this is what happens next. It is never done on the same day.
Even with advanced imaging, a biopsy remains an essential step when specific clinical signals indicate that examining tissue under a microscope is necessary. A biopsy is never done on day one. Your consultant reviews the images on screen with you first and talks through the next step calmly.
- The scan identifies a distinct, suspicious focal area graded PI-RADS 4 or 5.
- An intermediate PI-RADS 3 finding alongside a high PSA density.
- A PSA that has risen rapidly and persistently over time.
- A prostate that feels abnormal on examination.
- A strong genetic family history.
When a biopsy is required, the modern standard of care is the transperineal approach, which has largely replaced the older transrectal method. The detail of how it is done, what recovery looks like and the risks involved is on our targeted biopsy page.
If you would rather go straight to a biopsy
Some men arrive having already made up their mind. This is what your consultant will say, and why it is worth hearing.
There are genuine exceptions where a scan cannot or should not come first. The most common involves men with medical contraindications to the scanner, such as non-compatible cardiac pacemakers, older metallic brain aneurysm clips, or metallic foreign bodies near the eyes. Others include men with severe claustrophobia who cannot tolerate the scanner despite medication, or significant hip metalwork that distorts the view of the prostate. In these cases we do not jump into a blind biopsy without a plan. We substitute the MRI with high-resolution transrectal ultrasound, Doppler vascular imaging and micro-ultrasound to map the gland before taking samples.
A different exception is a man who arrives with unequivocal evidence of locally advanced or metastatic disease, such as a rock-hard, fixed prostate on examination paired with a PSA in the hundreds. There, staging imaging or a PSMA PET scan defines the spread, and a biopsy is performed promptly to establish the cell type and start treatment.
The more common situation is a man with a mildly raised PSA and understandable anxiety, who asks for an immediate needle biopsy because tissue in a lab feels more definitive than pictures on a screen.
What I explain to him is that demanding a biopsy without an MRI first is like asking an archer to shoot in a dark room. Without a pre-biopsy MRI, a surgeon is forced to take random, systematic bites of tissue across the prostate, hoping by chance to hit a problem area.
A blind biopsy can pass right next to an aggressive cancer in the front of the gland and miss it entirely, leaving you with false reassurance and a missed diagnosis. At the same time, blind sampling frequently snags tiny, harmless cells that never would have caused trouble, saddling you with a lifetime cancer label and treatment anxiety you did not need.
Performing the MRI first does not delay care. It ensures that if a biopsy is genuinely necessary, it is done safely, accurately, and targeted precisely at the target rather than fired at random.
Written and medically reviewed
Mr Ashwin Sridhar, Consultant Urological Surgeon
Last reviewed 1 September 2026.
Other guides worth reading
- I have been told I need a biopsyThe targeted prostate biopsyWhen a biopsy is needed, what the day involves, and the recovery and risk figures in full.
- What will this cost meWhat prostate diagnosis costsWhat the fee covers and what sits outside it, insurance or self-pay, and how the NHS route compares.
- My PSA came back raisedA raised PSA is not a diagnosisWhat the number actually means, the harmless reasons it rises, and who genuinely needs a scan.
Questions men ask
Can't find yours? Get in touch and our team will answer it.
Get the whole answer in one visit
The Complete Assessment brings the consultation, bloods, examination and MRI into one Harley Street morning, with a consultant's answer within a week. £2,500, everything included.